At a glance
ClinicalIndex Comparison RecordN/ACompleted· 635 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Dyslipidemia: REsidual and Mixed Abnormalities IN Spite of Statin Therapy: The Dyslipidemia REMAINS Study: A Multicenter, Prospective, Observational Study of Lipid Profiles and Treatment Patterns at Presentation and After 12 Weeks of Statin Therapy Among Indian Adults Presenting With First Coronary Event
In Brief
An observational study for Dyslipidemias and 4 related conditions. Completed, enrolled 635 participants.
Detailed Summary
The current study is proposed to investigate the pattern of dyslipidemia and of lipid treatment practices in patients in India experiencing their first acute cardiovascular event and the extent of residual dyslipidemia after 12 weeks of treatment with statins. Dyslipidemia definitions are per the National Cholesterol Education Program - Adult Treatment Panel III (NCEP-ATP III).
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsDyslipidemias, Hypercholesterolemia, Hypertriglyceridemia, High LDL-C, Low HDL-C
Countries--
Collaborators--
Timeline
N/ACompletedFinished
2011201220132014201520162017201820192020202120222023202420252026
Enrollment StartAug 2010
First PostedNov 2010
Primary CompletionDec 2012
TodayJul 2026
First PostedNov 22, 2010
Enrollment StartAug 1, 2010
Primary CompletionDec 1, 2012
TodayJul 2, 2026
Enrollment to primary: 2.3 yearsPosted 15.6 years ago